Clinical Trial Update: Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three doses of a new Lamaline formulation for knee osteoarthritis (gonarthrosis) has been completed to assess analgesic effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Lamaline

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED